Lukas Biomedical Inc. (TPEX:6814)
Taiwan
· Delayed Price · Currency is TWD 27.20
+0.70 (2.64%)
Mar 10, 2026, 1:21 PM CST
Lukas Biomedical Revenue
Lukas Biomedical had revenue of 87.92M TWD in the half year ending June 30, 2025, a decrease of -23.06%. This brings the company's revenue in the last twelve months to 180.32M, down -16.12% year-over-year. In the year 2024, Lukas Biomedical had annual revenue of 189.83M, down -18.12%.
Revenue (ttm)
180.32M
Revenue Growth
-16.12%
P/S Ratio
6.15
Revenue / Employee
1.88M
Employees
96
Market Cap
1.11B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Holy Stone Healthcare | 47.51M |
| Level Biotechnology | 736.59M |
| GeneReach Biotechnology | 215.32M |
| Enimmune | 42.23M |
| Taiwan Advance Bio-Pharmaceutical | 371.86M |
| TCI GENE | 324.73M |
| NatureWise Biotech & Medicals | 180.29M |
| Neith | 39.35M |